Company: GIFLF
Filing Date: 2025-02-26
Form Type: 6-K
Source: 0001104659-25-017501
Chunk: 26

Company: Grifols SA
Filing Date: 2025-02-26
Form: 6-K
Chunk 26
---
% 18.8% 20.9% Restructuring costs 1,889 21,673 10,095 2,326 35,982 159,343 19,916 Transaction costs 9,306 7,882 16,145 15,318 48,650 47,602 19,590 Impairments 24,265 787 - - 25,052 1,794 1,794 Biotest Next Level Project 7,340 5,113 4,922 16,798 34,173 33,100 33,100 SRAAS One-off - - (5,618) - (5,618) - - Other non-recurring items 1,155 1,245 1,613 6,020 10,032 (18,830) - Total adjustments 43,954 36,700 27,157 40,461 148,271 223,009 74,400 Adjusted EBITDA 525,944 462,098 440,788 350,402 1,779,232 1,461,589 443,522 % Net revenue 26.6% 25.8% 24.2% 21.6% 24.7% 22.2% 25.1% Q4 2024 Q1 2024 FY 2024 FY 2023Q2 2024Q3 2024 Q4 2023 Depreciation & Amortization OPERATING RESULT (EBIT)

- 36 - Q4 2024 Results Leverage Ratio as per Credit Agreement Introductory Remarks Business Performance Financials Final remarks Annex In millions of euros except ratio. Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Non-Current Financial Liabilities 9,491 8,836 8,752 9,650 10,034 Non-recurrent Lease Liabilities (IFRS16) (1,025) (969) (1,025) (1,026) (1,004) Current Financial Liabilities 676 1,017 2,757 1,745 1,023 Recurrent Lease Liabilities (IFRS16) (117) (111) (109) (111) (107) Cash and Cash Equivalents (980) (645) (2,113) (